Upgrade to SI Premium - Free Trial

Seattle Genetics (SGEN) PT Raised to $77 at H.C. Wainwright

February 7, 2018 7:24 AM
H.C. Wainwright raised its price target on Seattle Genetics (NASDAQ: SGEN) to $77.00 (from $75.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles